Progenics Pharmaceuticals (PGNX)

Create an Alert
4.81 +0.05  +1.05%   NASDAQ Jun 18, 8:00PM BATS Real time Currency in USD

Progenics Pharmaceuticals Cash from Operations Quarterly:

-5.551M for March 31, 2013
View Full Chart

Progenics Pharmaceuticals Cash from Operations Quarterly Chart

    Progenics Pharmaceuticals Historical Cash from Operations Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -5.551M
    Dec. 31, 2012 -5.73M
    Sept. 30, 2012 -6.825M
    June 30, 2012 -8.295M
    March 31, 2012 -13.79M
    Dec. 31, 2011 -8.401M
    Sept. 30, 2011 -5.372M
    June 30, 2011 -7.333M
    March 31, 2011 39.49M
    Dec. 31, 2010 -11.34M
    Sept. 30, 2010 -11.61M
    June 30, 2010 -10.80M
    March 31, 2010 -12.65M
    Dec. 31, 2009 -11.68M
    Sept. 30, 2009 -11.89M
    June 30, 2009 -11.72M
    March 31, 2009 -14.52M
    Dec. 31, 2008 4.611M
    Sept. 30, 2008 -12.60M
    June 30, 2008 -3.885M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Operations

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

    Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
    Learn More

    Get data for

    PGNX Cash from Operations Quarterly Benchmarks

    Companies
    Santarus -0.201M
    Salix Pharmaceuticals 211.23M
    Jazz Pharmaceuticals 65.89M

    PGNX Cash from Operations Quarterly Rankings

    Overall 56th percentile
    7214 of 16773
    Sector 49th percentile
    710 of 1408 in Healthcare
    Industry 53rd percentile
    209 of 453 in Biotechnology

    PGNX Cash from Operations Quarterly Range, Past 5 Years

    Minimum -14.52M Mar 2009
    Maximum 39.49M Mar 2011
    Average -6.495M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');